Zinzino: Strategic Co-Ownership in Xion to Enhance Omega-3 Production

Zinzino AB, a Swedish company specializing in biotechnology and health supplements, has entered negotiations to acquire a 35% stake in Xion International Group, an Andorra-based company known for its pioneering photobioreactor technology for spirulina production. This strategic move aims to enhance Zinzino's portfolio with sustainable, algae-derived omega-3 solutions. By securing co-ownership, Zinzino plans to leverage Xion’s intellectual property and scale its proprietary BalanceOil+ supplement production globally. This partnership aligns with Zinzino’s growth strategy, which has included recent acquisitions and is aimed at expanding into new markets and ensuring a sustainable supply of raw materials. Xion, currently a small-scale operation with sales of about EUR 1.3 million, offers Zinzino the opportunity to integrate high-tech algae production methods into its business model, mitigating reliance on traditional fish oil resources. The joint venture is expected to form a new entity, PhytoFerm, focusing on next-generation bioreactor-based nutritional solutions. The negotiations are anticipated to conclude in the second half of 2025, marking a significant step in Zinzino's ambition to lead the omega-3 market.